Hematology and Oncology

EmailEmail    |   Bookmark Page Bookmark  |   RSS Feeds RSS  |   Print Page Print  

Karen Carlson, MD, PhD

Karen Carlson, MD, PhD

Assistant Professor of Medicine

Karen-Sue Barker Carlson, MD, PhD, is Assistant Professor of Medicine at the Medical College of Wisconsin, Division of Hematology and Oncology, specializing in acute and chronic myeloid leukemia, myelodysplastic syndromes and myeloproliferative disorders. She received her MD and PhD in 2004 from the University of Wisconsin – Madison. In 2006, she completed her postdoctoral fellowship at The Rockefeller University in New York.  She was awarded the F.M. Kirby Postdoctoral Fellowship in Sensory Neuroscience during her fellowship.  Dr. Carlson completed her residency in internal medicine and subsequent Fellowship in Hematology and Medical Oncology at Weill Cornell Medical Center, New York Presbyterian Hospital, New York. In her final year, Dr. Carlson served as Chief Hematology and Oncology Fellow.  Dr. Carlson held the position of Assistant Professor, Department of Medicine, Division of Hematology and Oncology at Weill Cornell Medical Center prior to joining MCW. Her basic and clinical research focus on the bone marrow microenvironment and its impact on normal and leukemic blood cell production.  Dr. Carlson is board certified in Internal Medicine and Hematology.

Refereed Journal Publications/Original Papers

 

1.    Barker-Carlson K, Lawrence D, Schwartz B.  Acyl-enzyme complexes between tissue type plasminogen activator and neuroserpin are short lived in vitro.  J. Biol. Chem. Nov 2002; 277:46852 – 46857. (PMID: 12228252)

 

2.    Carlson K, DeSancho MT.  Hematological Issues in Critically Ill Patients with Cancer.  Critical Care Clinics.  January 2010; Volume 26 (1): 107-132. (PMID: 19944278)

 

3.    Mallik A, Carlson KB, DeSancho MT.  A Patient with “Spontaneous” Heparin-induced Thrombocytopenia and Thrombosis after Undergoing Knee Replacement, Blood Coagulation and Fibrinolysis. Blood Coagulation and Fibrinolysis. January 2011; 22(1):73-5. (PMID: 21076280)

 

4.    Carlson K, Singh P, Feaster M, Ramnarain A, Pavlides C, Chen ZL, Yu WM, Feltri ML, Strickland S.  Mesenchymal Stem Cells Facilitate Axon Sorting, Myelination, and Functional Recovery in Paralyzed Mice Deficient in Schwann Cell-Derived Laminin.  Glia. Feb 2011; 59(2):267-77. (PMID: 21125647; PMCID: PMC3118468)

 

5.    Carlson K, Ocean A.  Peripheral Neuropathy with Microtubule-targeting Agents: Occurrence and Management Approach.  Clinical Breast Cancer. Apr 2011; 11(2): 73-81. (PMID: 21569993)

 

6.    Ritchie EK, Feldman EJ, Christos PJ, Rohan SD, Lagassa CB, Ippoliti C, Scandura JM, Carlson K, Roboz GJ.  Decitabine in patients with newly diagnosed and relapsed acute myeloid leukemia.  Leukemia and Lymphoma. Sep 2013; 54(9):2003-7.  (PMID: 23270581)

 

7.    Carlson Karen-Sue B, Guzman Monica L.  Is Minimal Residual Disease Monitoring Clinically Relevant in Adults with Acute Myelogenous Leukemia?  Current Hematologic Malignancy Reports.  Jun 2013; 8(2):109-115. (PMID: 23563936)

 

8.  Chapin J, Carlson K, Christos PJ, Desancho MT.  Risk Factors and Treatment Strategies in Patients with Retinal Vascular Occlusions.  Clin Appl Thromb Hemostasis.  Dec 2013; Epub ahead of print.  (PMID 24335246)

 

 

webmaster@mcw.edu
© 2014 Medical College of Wisconsin
Page Updated 11/04/2014